Home / Inspections / 1064090

FDA Inspection 1064090 — Jubilant Cadista Pharmaceuticals

Jubilant Cadista Pharmaceuticals — FEI 3017221809

The FDA completed an inspection of Jubilant Cadista Pharmaceuticals on May 4, 2018 in Yardley, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 4, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Yardley, PA (United States)

Facility

Other inspections at this facility

  • 1257696 (VAI Wed Jan 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1120136 (VAI Fri Feb 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 940733 (VAI Fri Aug 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 888209 (NAI Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 842669 (NAI Thu Aug 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources